Building solutions for women with science at the core. 👩‍🔬
Location: United Kingdom, England, London
Employees: 1-10
Total raised: $2.3M
Founded date: 2021
Investors 3
| Date | Name | Website |
| - | FIRSTPICK | firstpick.... |
| - | Seaside Ve... | seasideven... |
| 03.12.2025 | CVX Ventur... | cvx.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.02.2024 | Pre-Seed | $2.3M | - |
Mentions in press and media 11
| Date | Title | Description |
| 08.03.2026 | Baltic Tech Boost: FIRSTPICK Launches €25M Fund for Early-Stage AI Innovators | FIRSTPICK launches a €25 million fund, targeting early-stage Baltic startups. The fund focuses on unconventional, overlooked founders in AI-first software. Initial checks are €100K to €500K, with follow-on up to €1 million. This initiative ... |
| 06.03.2026 | FIRSTPICK: €25 Million Fund Launched To Back Early-Stage Baltic Startup Founders | Vilnius-based venture capital firm FIRSTPICK has launched a €25 million fund to support early-stage startups across the Baltic region, with a focus on founders who may not fit traditional venture capital profiles. The new fund will target s... |
| 05.03.2026 | FIRSTPICK launches €25 million fund to act as VC “fairy godmother” to Baltic founders before their Cinderella moment | FIRSTPICK, a Vilnius-based first-check venture capital fund, has launched a new €25 million fund to invest in early-stage Baltic startups. It focuses on founders who don’t fit the typical VC mould and are open to entrepreneurs with no FAANG... |
| 05.03.2026 | FIRSTPICK raises €25M to find the Baltics’ next breakout founders | Vilnius-based first-check VC fund FIRSTPICK has launched a new €25 million fund focused on early-stage investments. The aim is to support Baltic founders who don’t fit the typical VC mold. No FAANG background or Ivy League degree needed. In... |
| 24.02.2024 | Samphire Neuroscience Revolutionizes Menstrual Health with Nettle Wearable | Samphire Neuroscience, a London-based startup, has raised a whopping $2.3 million in Pre-Seed funding to launch Nettle, a groundbreaking neurostimulation wearable designed to target PMS and menstrual pain. This innovative device aims to pro... |
| 23.02.2024 | Samphire Neuroscience secures $2.3M Pre-Seed to launch menstrual health wearable | This week menstrual health gets a boost as medtech startup Samphire Neuroscience secured $2.3 million in Pre-Seed funding to launch Nettle, a medical-grade neurostimulation wearable. Over 90 per cent of women of reproductive age will experi... |
| 21.02.2024 | Samphire Neuroscience is building a brain stimulating wearable for period pain | It’s a horrible truth that many women simply endure period pain every month — perhaps relying on painkillers or a hot water bottle to relieve stomach cramps. For others, menstrual pain can be inescapably debilitating — to the point where th... |
| 21.02.2024 | London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain | - |
| 15.03.2023 | New Cohort and major partner for Tech4Eva Accelerator | |
| - | Samphire Neuroscience | “Struggling with mood swings, period pain, or low energy before your period? Nettle™ offers safe, drug-free, non-invasive brain stimulation—clinically proven for PMDD, PMS & Endometriosis. Pair it with the Samphire App, a science-backed... |
Show more